Jpmorgan Chase & CO Jaguar Health, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.08 - $809.55 $1,810 - $18.3 Million	-22,631 Reduced 54.18%	19,137 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $1,306 - $5.88 Million	-7,686 Reduced 15.54%	41,768 $7,000
Q2 2022 Aug 11, 2022	BUY	$0.27 - $0.71 $7,728 - $20,323	28,625 Added 137.43%	49,454 $15,000
Q1 2022 May 11, 2022	SELL	$0.38 - $1.07 $26,974 - $75,953	-70,985 Reduced 77.31%	20,829 $15,000
Q4 2021 Feb 10, 2022	BUY	$1.03 - $2.48 $94,568 - $227,698	91,814 New	91,814 $95,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $125M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.